Similar Posts
Scientific data so far lacking
Eric Lichtblau (NY Times) and Robert Roos (Center for Infectious Disease Research & Policy ) have written two comprehensive articles discussing the scientific and other evidence that has been presented. Lichtblau also discusses a closed-door FBI briefing that took place on August 14. They conclude the case is found seriously wanting.
According to the CDC’s National Center for Health Statistics, life expectancy has dropped 3 years to 76 from 79 since the start of the pandemic
From STAT: Life expectancy for Americans born in 2021 is just 76.1 years. That’s the lowest since 1966 and the steepest decline in almost 100 years. It’s astonishing to people who closely follow these data, prompting comparisons to the drop after another pandemic: the Spanish Flu of 1918. “It’s a ridiculous decline,” Bob Anderson, chief…
Pfizer “Vaccine” Lot Sizes Do NOT Explain the Abnormal Lot-to-Lot Variability in Adverse Events and Deaths/ Latypova, TrialSite News
https://www.trialsitenews.com/a/pfizer-vaccine-lot-sizes-do-not-explain-the-abnormal-lot-to-lot-variability-in-adverse-events-and-deaths-32e126eb I told you so! Data obtained through FOIA. Background: My colleagues and I have been analyzing CDC VAERS data since the start of the mass “vaccination” worldwide. While many good researchers and doctors have rightfully called attention to the catastrophically high levels of adverse events, serious adverse events, and deaths associated with mRNA injections, our group…
Emergent Biosolutions Hits New 52-Week High On Positive Outlook
Mayur Pahilajani – iStockAnalyst WriterNew York, NY Shares of Emergent Biosolutions Inc (NYSE: EBS) topped 52-week mark after the bell on Friday as investors gained confidence in the company after the Rockville-based biotech’s profitable anthrax treatments won emergency protection. On October 9, the firm announced that the vaccine Biothrax and its Anthrax Immune Globulin, both…
Vaccine industry is being revived: New technology, greater funding and higher profits are a shot in the arm for advances/ LA Times
I will be talking more about how the H1N1 pandemic was exploited to greatly expand the use of vaccines, in the near future. This January 28, 2007 article by Daniel Costello in the LA Times provides important background on this whole issue, and begins to unravel the interconnected roles of large charitable organizations and big…
My interview yesterday with Kristina Borjesson on all things Monkeypox
https://tntradiolive.podbean.com/e/dr-meryl-nass-on-kristina-borjesson-show-31-july-2022/